145 related articles for article (PubMed ID: 21131771)
1. Synchronous carcinoma breast with chronic myelogenous leukemia: a rare presentation.
Bahl A; Dhiman A; Talwar V; Doval DC
Indian J Cancer; 2010; 47(4):477-9. PubMed ID: 21131771
[No Abstract] [Full Text] [Related]
2. Case 3: infiltrating ductal breast carcinoma.
Peoples GE; Arciero C; Adair C; Shriver CD;
Oncology (Williston Park); 2004 Apr; 18(4):437-8, 440. PubMed ID: 15134352
[No Abstract] [Full Text] [Related]
3. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient.
Porta C; Casagranda I; Semino G; Moroni M; Ratto C
Haematologica; 1993; 78(1):56-7. PubMed ID: 8387943
[No Abstract] [Full Text] [Related]
4. Synchronous bilateral breast cancer in a patient with kindler syndrome.
Tonyali O; Tufan G; Benekli M; Coskun U; Buyukberber S
Clin Breast Cancer; 2012 Apr; 12(2):145-6. PubMed ID: 22054710
[No Abstract] [Full Text] [Related]
5. Extramedullary hematopoiesis in breast after neoadjuvant chemotherapy for breast carcinoma.
Wang J; Darvishian F
Ann Clin Lab Sci; 2006; 36(4):475-8. PubMed ID: 17127738
[TBL] [Abstract][Full Text] [Related]
6. Synchronous occurrence of Philadelphia chromosome-positive chronic myelogenous leukemia and breast cancer.
Tillawi IS
Saudi Med J; 2007 Feb; 28(2):291-4. PubMed ID: 17268717
[No Abstract] [Full Text] [Related]
7. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia.
Koca E; Sevimli F; Cetiner D; Haznedaroglu IC; Sayinalp N; Büyükasik Y; Goker H; Ozcebe O
Am J Hematol; 2007 Apr; 82(4):333. PubMed ID: 17094091
[No Abstract] [Full Text] [Related]
8. Treatment of mammographically detected minimal breast cancer in an older woman.
Hall TC; Shokeir MO; Taylor MA; Wreggit GR; Crabo L
Med Pediatr Oncol; 2000 Jan; 34(1):53-7; discussion 58. PubMed ID: 10611586
[No Abstract] [Full Text] [Related]
9. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Francis P; Crown J; Di Leo A; Buyse M; Balil A; Andersson M; Nordenskjöld B; Lang I; Jakesz R; Vorobiof D; Gutiérrez J; van Hazel G; Dolci S; Jamin S; Bendahmane B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Piccart-Gebhart M;
J Natl Cancer Inst; 2008 Jan; 100(2):121-33. PubMed ID: 18182617
[TBL] [Abstract][Full Text] [Related]
10. Dose-intensive therapy for breast cancer.
O'Shaughnessy JA; Cowan KH
JAMA; 1993 Nov; 270(17):2089-92. PubMed ID: 8411576
[No Abstract] [Full Text] [Related]
11. Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy?
Henry NL; Hayes DF
J Clin Oncol; 2007 Jun; 25(18):2501-3. PubMed ID: 17577024
[No Abstract] [Full Text] [Related]
12. Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099.
Alvarez RH; Booser DJ; Cristofanilli M; Sahin AA; Strom EA; Guerra L; Kau SW; Gonzalez-Angulo AM; Hortobagyi GN; Valero V
Cancer; 2010 Mar; 116(5):1210-7. PubMed ID: 20082452
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
14. Bilateral synchronous breast carcinomas followed by a metastasis to the gallbladder: a case report.
Zagouri F; Sergentanis TN; Koulocheri D; Nonni A; Bousiotou A; Domeyer P; Michalopoulos NV; Dardamanis D; Konstadoulakis MM; Zografos GC
World J Surg Oncol; 2007 Sep; 5():101. PubMed ID: 17848197
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from an unusual case of inflammatory breast cancer.
Harrison AM; Zendejas B; Ali SM; Scow JS; Farley DR
J Surg Educ; 2012; 69(3):350-4. PubMed ID: 22483137
[TBL] [Abstract][Full Text] [Related]
16. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
Kuo SH; Chen CL; Huang CS; Cheng AL
Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials referral resource. Adjuvant therapy of breast cancer.
Cheson BD
Oncology (Williston Park); 1989 Jun; 3(6):70-1, 74-5, 78. PubMed ID: 2534915
[No Abstract] [Full Text] [Related]
18. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
von Minckwitz G; Untch M; Blohmer JU; Costa SD; Eidtmann H; Fasching PA; Gerber B; Eiermann W; Hilfrich J; Huober J; Jackisch C; Kaufmann M; Konecny GE; Denkert C; Nekljudova V; Mehta K; Loibl S
J Clin Oncol; 2012 May; 30(15):1796-804. PubMed ID: 22508812
[TBL] [Abstract][Full Text] [Related]
19. A 42-year-old woman with breast cancer.
Crawford ED
Oncology (Williston Park); 2003 May; 17(5):614; discussion 615-20. PubMed ID: 12800791
[TBL] [Abstract][Full Text] [Related]
20. Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias.
Stagno F; Vigneri P; Del Fabro V; Stella S; Restuccia N; Giallongo C; Massimino M; Berretta S; Pennisi MS; Tibullo D; Tirrò E; Buscarino C; Messina A; Di Raimondo F
Acta Oncol; 2010; 49(1):109-10. PubMed ID: 19842797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
